Asian Growth Companies With High Insider Ownership To Watch

As global markets navigate a landscape marked by trade tensions and regulatory uncertainties, Asian economies are also feeling the ripple effects, with notable declines in major indices like China's CSI 300 and Japan's Nikkei 225. In this environment of heightened volatility, growth companies with high insider ownership can offer unique insights into potential resilience and long-term value creation.

Top 10 Growth Companies With High Insider Ownership In Asia

Name	Insider Ownership	Earnings Growth
Jiayou International LogisticsLtd (SHSE:603871)	19.3%	27.3%
Seojin SystemLtd (KOSDAQ:A178320)	32.1%	39.9%
Sineng ElectricLtd (SZSE:300827)	36.3%	41.4%
PharmaResearch (KOSDAQ:A214450)	38.6%	26.4%
Laopu Gold (SEHK:6181)	36.4%	42.4%
WinWay Technology (TWSE:6515)	22.6%	32.8%
Oscotec (KOSDAQ:A039200)	21.2%	148.5%
HANA Micron (KOSDAQ:A067310)	18.3%	125.9%
Fulin Precision (SZSE:300432)	13.6%	71%
Zhejiang Leapmotor Technology (SEHK:9863)	15.2%	60%

Click here to see the full list of 642 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Shanghai Titan Scientific (SHSE:688133)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Shanghai Titan Scientific Co., Ltd. offers laboratory products and supporting services for scientific researchers and quality control personnel, with a market cap of CN¥3.91 billion.

Operations: Revenue segments for SHSE:688133 include laboratory products and supporting services tailored to scientific researchers and quality control personnel.

Insider Ownership: 28.2%

Earnings Growth Forecast: 73.9% p.a.

Shanghai Titan Scientific's earnings are expected to grow significantly, outpacing the Chinese market, despite a recent decline in profit margins and net income. The company's revenue growth, while slower than desired at 13.9% annually, still surpasses the broader market rate. Recent exclusion from the S&P Global BMI Index may raise concerns; however, it trades at a good value relative to peers. No substantial insider trading activity has been reported recently.

• Dive into the specifics of Shanghai Titan Scientific here with our thorough growth forecast report.
• Upon reviewing our latest valuation report, Shanghai Titan Scientific's share price might be too pessimistic.

ApicHope Pharmaceutical Group (SZSE:300723)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: ApicHope Pharmaceutical Group Co., Ltd. is involved in the research, development, production, and sale of pharmaceutical drugs, with a market cap of CN¥8.82 billion.

Operations: The company's revenue is derived from its activities in research, development, production, and sale of pharmaceutical drugs.

Insider Ownership: 19.2%

Earnings Growth Forecast: 112.4% p.a.

ApicHope Pharmaceutical Group is expected to achieve significant earnings growth of 112.36% annually, surpassing the Chinese market's average. However, its revenue growth forecast of 17.3% per year falls short of the desired 20%. The company faces challenges with high volatility in share price and a low return on equity projection at 11.4%. Recent events include a shareholders meeting to discuss a stock option incentive plan, indicating ongoing strategic initiatives for internal stakeholders.

• Click here to discover the nuances of ApicHope Pharmaceutical Group with our detailed analytical future growth report.
• The valuation report we've compiled suggests that ApicHope Pharmaceutical Group's current price could be inflated.

QuakeSafe Technologies (SZSE:300767)

Simply Wall St Growth Rating: ★★★★★☆

Overview: QuakeSafe Technologies Co., Ltd. specializes in developing, producing, and selling anti-seismic and shock absorber products in China with a market cap of CN¥3.12 billion.

Operations: QuakeSafe Technologies generates revenue through its development, production, and sale of anti-seismic and shock absorber products within China.

Insider Ownership: 18.2%

Earnings Growth Forecast: 82.2% p.a.

QuakeSafe Technologies is poised for substantial growth, with earnings projected to increase 82.23% annually and revenue expected to rise by 28.4% per year, outpacing the Chinese market average. Despite trading at a significant discount of 80.2% below estimated fair value, its return on equity remains low at a forecasted 3.2%. Recent shareholder meetings have focused on strategic decisions like appointing an internal control audit firm and amending company articles, highlighting active governance involvement.

• Delve into the full analysis future growth report here for a deeper understanding of QuakeSafe Technologies.
• Our valuation report unveils the possibility QuakeSafe Technologies' shares may be trading at a premium.

Taking Advantage

• Explore the 642 names from our Fast Growing Asian Companies With High Insider Ownership screener here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com